Chromadex Corp Share Price OTC Bulletin Board
Stocks
CDXC
US1710771007
Biotechnology & Medical Research
|
End-of-day quote
OTC Bulletin Board
|
||
| - USD | - |
|
| Market Cap | 24Cr 21Cr 20Cr 18Cr 34Cr 2.32TCr 34Cr 239.85Cr 93Cr 1.18TCr 91Cr 89Cr 3.81TCr | P/E 2026 * |
22.8x | P/E 2027 * | 19.8x |
|---|---|---|---|---|---|
| Enterprise Value | 24Cr 21Cr 20Cr 18Cr 34Cr 2.32TCr 34Cr 239.85Cr 93Cr 1.18TCr 91Cr 89Cr 3.81TCr | EV / Sales 2026 * |
1.82x | EV / Sales 2027 * | 1.56x |
| Free-Float |
70.54% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Chromadex Corp
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Fried
CEO | Chief Executive Officer | 66 | 01/06/2018 |
Ozan Pamir
DFI | Director of Finance/CFO | 35 | 21/10/2024 |
Mona Rosene
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Frank Jaksch
CHM | Chairman | 57 | 22/06/2018 |
Robert Fried
BRD | Director/Board Member | 66 | 09/07/2015 |
Steven Rubin
BRD | Director/Board Member | 65 | 27/03/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.14% | +4.33% | +9.88% | +31.73% | 4.8TCr | |
| -1.69% | +1.48% | +53.02% | +33.59% | 4.45TCr | |
| +2.56% | +7.34% | +382.17% | +594.81% | 4.39TCr | |
| +0.24% | +2.85% | +9.78% | +89.54% | 4.1TCr | |
| -0.62% | -1.11% | +4.70% | +46.02% | 2.99TCr | |
| -0.28% | +1.07% | +26.83% | +152.91% | 1.73TCr | |
| -0.46% | +1.20% | +26.78% | +41.32% | 1.53TCr | |
| -2.21% | -4.70% | - | - | 1.48TCr | |
| +3.37% | +9.21% | +9.93% | - | 1.53TCr | |
| Average | +0.09% | +2.35% | +65.39% | +141.42% | 3TCr | |
| Weighted average by Cap. | +0.11% | +2.86% | +83.03% | +156.21% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13Cr 12Cr 11Cr 10Cr 19Cr 1.28TCr 19Cr 132.01Cr 51Cr 651.79Cr 50Cr 49Cr 2.09TCr | 16Cr 14Cr 13Cr 12Cr 22Cr 1.49TCr 22Cr 154.02Cr 60Cr 760.46Cr 58Cr 57Cr 2.44TCr |
| Net income | 1.09Cr 95.51L 90.21L 82.21L 1.54Cr 104.32Cr 1.55Cr 11Cr 4.18Cr 53Cr 4.09Cr 4Cr 171.29Cr | 1.28Cr 1.13Cr 1.06Cr 96.84L 1.81Cr 122.89Cr 1.83Cr 13Cr 4.93Cr 63Cr 4.81Cr 4.71Cr 201.77Cr |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- NAGE Stock
- CDXC Stock
Select your edition
All financial news and data tailored to specific country editions
